Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Expansion of Tumor-Infiltrating CD8⁺ T cells Expressing PD-1 Improves the Efficacy of Adoptive T-cell Therapy

Sarita M. Fernandez-Poma, Diego Salas-Benito, Teresa Lozano, Noelia Casares, Jose-Ignacio Riezu-Boj, Uxua Mancheño, Edurne Elizalde, Diego Alignani, Natalia Zubeldia, Itziar Otano, Enrique Conde, Pablo Sarobe, Juan Jose Lasarte, Sandra Hervas-Stubbs

Cancer Res (2017) 77 (13): 3672–3684.

https://doi.org/10.1158/0008-5472.CAN-17-0236

Published: 02 July 2017

View article titled, Expansion of Tumor-Infiltrating CD8<sup>+</sup> T cells Expressing PD-1 Improves the Efficacy of Adoptive T-cell Therapy

Includes: Supplementary data

Journal Articles

Abstract 1059: Enhanced anti-tumor efficacy of a checkpoint inhibitor in combination with the HDAC inhibitor belinostat in a murine hepato-cellular carcinoma preclinical model

Diana Llopiz, Marta Ruiz, Perrine Pivette, Véronique Trochon-Joseph, Bérangère Vasseur, Caroline Lemarchand, Graham Dixon, Pablo Sarobe, Bruno Sangro

Cancer Res (2017) 77 (13_Supplement): 1059.

https://doi.org/10.1158/1538-7445.AM2017-1059

Published: 01 July 2017

View article titled, Abstract 1059: Enhanced anti-tumor efficacy of a checkpoint inhibitor in combination with the HDAC inhibitor belinostat in a murine hepato-cellular carcinoma preclinical model

Journal Articles

Abstract 4387: Antiviral and antitumoral effects of the anti-CTLA4 agent tremelimumab in patients with hepatocellular carcinoma (HCC) and chronic hepatitis C virus (HCV) infection: Results from a phase II clinical trial

Ignacio Melero, Bruno Sangro, Jose I. Riezu-Boj, Mercedes Iñarrairaegui, Juan J. Lasarte, Pablo Sarobe, Esther Larrea, Jesus Prieto

Cancer Res (2012) 72 (8_Supplement): 4387.

https://doi.org/10.1158/1538-7445.AM2012-4387

Published: 15 April 2012

View article titled, Abstract 4387: Antiviral and antitumoral effects of the anti-CTLA4 agent tremelimumab in patients with hepatocellular carcinoma (HCC) and chronic hepatitis C virus (HCV) infection: Results from a phase II clinical trial

Journal Articles

Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors

Fernando Aranda, Diana Llopiz, Nancy Díaz-Valdés, José Ignacio Riezu-Boj, Jaione Bezunartea, Marta Ruiz, Marta Martínez, Maika Durantez, Cristina Mansilla, Jesús Prieto, Juan José Lasarte, Francisco Borrás-Cuesta, Pablo Sarobe

Cancer Res (2011) 71 (9): 3214–3224.

https://doi.org/10.1158/0008-5472.CAN-10-3259

Published: 29 April 2011

View article titled, Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors

Includes: Supplementary data

Journal Articles

Induction of Monocyte Chemoattractant Protein-1 and Interleukin-10 by TGFβ1 in Melanoma Enhances Tumor Infiltration and Immunosuppression

Nancy Díaz-Valdés, María Basagoiti, Javier Dotor, Fernando Aranda, Iñaki Monreal, José Ignacio Riezu-Boj, Francisco Borrás-Cuesta, Pablo Sarobe, Esperanza Feijoó

Cancer Res (2011) 71 (3): 812–821.

https://doi.org/10.1158/0008-5472.CAN-10-2698

Published: 01 February 2011

View article titled, Induction of Monocyte Chemoattractant Protein-1 and Interleukin-10 by TGFβ1 in Melanoma Enhances Tumor Infiltration and Immunosuppression

Includes: Supplementary data

Journal Articles

Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor Immunity

Eduardo Huarte, Juan R. Cubillos-Ruiz, Yolanda C. Nesbeth, Uciane K. Scarlett, Diana G. Martinez, Ronald J. Buckanovich, Fabian Benencia, Radu V. Stan, Tibor Keler, Pablo Sarobe, Charles L. Sentman, Jose R. Conejo-Garcia

Cancer Res (2008) 68 (18): 7684–7691.

https://doi.org/10.1158/0008-5472.CAN-08-1167

Published: 14 September 2008

View article titled, Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor Immunity

Includes: Supplementary data

NARROW

Expansion of Tumor-Infiltrating CD8⁺ T cells Expressing PD-1 Improves the Efficacy of Adoptive T-cell Therapy

Abstract 1059: Enhanced anti-tumor efficacy of a checkpoint inhibitor in combination with the HDAC inhibitor belinostat in a murine hepato-cellular carcinoma preclinical model

Abstract 4387: Antiviral and antitumoral effects of the anti-CTLA4 agent tremelimumab in patients with hepatocellular carcinoma (HCC) and chronic hepatitis C virus (HCV) infection: Results from a phase II clinical trial

Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors

Induction of Monocyte Chemoattractant Protein-1 and Interleukin-10 by TGFβ1 in Melanoma Enhances Tumor Infiltration and Immunosuppression

Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor Immunity

Email alerts

AACR Journals

Expansion of Tumor-Infiltrating CD8+ T cells Expressing PD-1 Improves the Efficacy of Adoptive T-cell Therapy

Abstract 1059: Enhanced anti-tumor efficacy of a checkpoint inhibitor in combination with the HDAC inhibitor belinostat in a murine hepato-cellular carcinoma preclinical model

Abstract 4387: Antiviral and antitumoral effects of the anti-CTLA4 agent tremelimumab in patients with hepatocellular carcinoma (HCC) and chronic hepatitis C virus (HCV) infection: Results from a phase II clinical trial

Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors

Induction of Monocyte Chemoattractant Protein-1 and Interleukin-10 by TGFβ1 in Melanoma Enhances Tumor Infiltration and Immunosuppression

Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor Immunity

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only

Expansion of Tumor-Infiltrating CD8⁺ T cells Expressing PD-1 Improves the Efficacy of Adoptive T-cell Therapy